Bi Electro
NDC Package 50066-285-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bi Electro is a . Marketed by Genomma Labs Usa, Inc, this product is identified by NDC 50066-285 and is authorized under FDA application part343.

Identification & Billing

NDC Package Code
50066-285-24
Package Description
1 BOTTLE in 1 CARTON / 24 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
50066028524

Clinical Specifications

Proprietary Name
Bi Electro Extra Strength
Dosage Form
-

Regulatory & Marketing

Labeler Name
Genomma Labs Usa, Inc
FDA Application #
part343
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
01-08-2015
End Marketing Date
09-20-2022
Listing Expiration
09-20-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50066-285-24 identifies a specific commercial package of 1 bottle in 1 carton / 24 tablet in 1 bottle of Bi Electro Extra Strength, labeled by Genomma Labs Usa, Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Genomma Labs Usa, Inc on January 08, 2015. The current certification is valid through September 20, 2022.

How is this Genomma Labs Usa, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50066028524. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50066-285-24
11-Digit CMS (5-4-2)
50066-0285-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.